NORTHERN TRUST CORP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$2,038,000
+327.3%
348,282
-5.1%
0.00%
Q4 2018$477,000
-61.8%
366,982
+1.3%
0.00%
Q3 2018$1,250,000
-23.2%
362,303
+1.2%
0.00%
Q2 2018$1,628,000
+53.0%
357,880
+11.0%
0.00%
Q1 2018$1,064,000
-15.3%
322,441
+0.1%
0.00%
Q4 2017$1,256,000
-31.5%
322,244
+82.0%
0.00%
Q3 2017$1,833,000
+3.9%
177,062
-2.1%
0.00%
Q2 2017$1,764,000
+90.5%
180,877
+32.8%
0.00%
Q1 2017$926,000
+32.9%
136,224
+7.5%
0.00%
Q4 2016$697,000
-23.5%
126,698
+5.4%
0.00%
Q3 2016$911,000
-11.9%
120,219
-5.1%
0.00%
Q2 2016$1,034,000
-41.9%
126,648
-7.6%
0.00%
-100.0%
Q1 2016$1,781,000
-35.4%
137,053
-0.1%
0.00%0.0%
Q4 2015$2,755,000
+86.4%
137,196
+13.2%
0.00%
Q3 2015$1,478,000
-18.3%
121,154
+38.3%
0.00%
-100.0%
Q2 2015$1,809,000
+38.6%
87,596
+41.6%
0.00%
Q1 2015$1,305,000
-22.3%
61,841
+13.3%
0.00%
-100.0%
Q4 2014$1,679,00054,5710.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders